Scott Barnhart
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Scott Barnhart has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Achilles Katamba
Clinical Epidemiology Unit, Makerere University, Kampala, Uganda
1 shared publication - Amy Hagopian
University of British Columbia, Vancouver, Canada
1 shared publication Andrew Glass
Kaiser Permanente Center for Health Research, Portland, Oregon
1 shared publicationBarbara Valanis
1 shared publicationCarl Brodkin
School of Public Health and Community Medicine, University of Washington, Seattle, Washington
1 shared publicationDiane Liu
Department of Medicine, University of California, San Francisco, California
1 shared publication
Latest Publications
- Open Access
- 1 August 2013
- Published by Springer Nature in BMC Health Services Research
- Vol. 13 (1) , 292
Use of surgical task shifting to scale up essential surgical services: a feasibility analysis at facility level in Uganda
The shortage and mal-distribution of surgical specialists in sub-Saharan African countries is born out of shortage of individuals choosing a surgical career, limited training capacity, inadequate remuneration, and reluctance on the part of professionals to work in rural and remote areas, among other reasons. This study set out to assess the views of clinicians and managers on the use of task shifting as an effective way of alleviating shortages of skilled personnel at a facility level.
- 1 August 2013
- Published by Springer Nature in BMC Health Services Research
- Vol. 13 (1) , 292
Open AccessUse of surgical task shifting to scale up essential surgical services: a feasibility analysis at facility level in Uganda
The shortage and mal-distribution of surgical specialists in sub-Saharan African countries is born out of shortage of individuals choosing a surgical career, limited training capacity, inadequate remuneration, and reluctance on the part of professionals to work in rural and remote areas, among other reasons. This study set out to assess the views of clinicians and managers on the use of task shifting as an effective way of alleviating shortages of skilled personnel at a facility level.
- 6 December 1997
- Published by Wiley in American Journal of Industrial Medicine
- Vol. 32 (6) , 573-581
The CARET asbestos-exposed cohort: Baseline characteristics and comparison to other asbestos-exposed cohorts
The Carotene and Retinol Efficacy Trial (CARET) was a double‐blind, placebo‐controlled trial of the daily administration of 25,000 IU vitamin A and 30 mg β‐carotene for the prevention of lung cancer. Of close to 18,500 participants, more than 4,000 were asbestos‐exposed men recruited from shipyard and construction trades at five study centers in the United States. While the primary endpoint of the trial was the incidence of lung cancer, a number of questions about the natural history of asbestos‐related disease will also be addressed. The mean age at entry into the trial was 57 years and the mean duration of follow‐up on active intervention was 4 years. With the exception of 133 never‐smoker pilot participants (3%), all subjects recruited were by intention current (38%) or ex‐smokers (58%), with a mean cumulative smoking exposure at entry of 43 pack‐years. Mean years from first asbestos exposure were 35, and mean duration of asbestos exposure in a high‐risk trade was 19 years. The distribution of radiographic abnormalities was as follows: normal, 34%; parenchymal opacities (ILO profusion score >1/0) alone, 18%; pleural thickening alone, 27%; both parenchymal opacities and pleural thickening, 21%. The CARET cohort, when compared to previously reported asbestos‐exposed cohorts, is characterized by substantial asbestos exposure and high proportion of asbestos‐related radiographic findings. The active intervention was halted in 1996, after a mean duration of 40 years. Passive follow‐up of the cohort will continue until the year 2000. Am. J. Ind. Med. 32:573‐581, 1997.
- 6 December 1997
- Published by Wiley in American Journal of Industrial Medicine
- Vol. 32 (6) , 573-581
The CARET asbestos-exposed cohort: Baseline characteristics and comparison to other asbestos-exposed cohorts
The Carotene and Retinol Efficacy Trial (CARET) was a double‐blind, placebo‐controlled trial of the daily administration of 25,000 IU vitamin A and 30 mg β‐carotene for the prevention of lung cancer. Of close to 18,500 participants, more than 4,000 were asbestos‐exposed men recruited from shipyard and construction trades at five study centers in the United States. While the primary endpoint of the trial was the incidence of lung cancer, a number of questions about the natural history of asbestos‐related disease will also be addressed. The mean age at entry into the trial was 57 years and the mean duration of follow‐up on active intervention was 4 years. With the exception of 133 never‐smoker pilot participants (3%), all subjects recruited were by intention current (38%) or ex‐smokers (58%), with a mean cumulative smoking exposure at entry of 43 pack‐years. Mean years from first asbestos exposure were 35, and mean duration of asbestos exposure in a high‐risk trade was 19 years. The distribution of radiographic abnormalities was as follows: normal, 34%; parenchymal opacities (ILO profusion score >1/0) alone, 18%; pleural thickening alone, 27%; both parenchymal opacities and pleural thickening, 21%. The CARET cohort, when compared to previously reported asbestos‐exposed cohorts, is characterized by substantial asbestos exposure and high proportion of asbestos‐related radiographic findings. The active intervention was halted in 1996, after a mean duration of 40 years. Passive follow‐up of the cohort will continue until the year 2000. Am. J. Ind. Med. 32:573‐581, 1997.